Literature DB >> 20031412

Synthesis and SAR of novel imidazoles as potent and selective cannabinoid CB2 receptor antagonists with high binding efficiencies.

Jos H M Lange1, Martina A W van der Neut, Henri C Wals, Gijs D Kuil, Alice J M Borst, Arie Mulder, Arnold P den Hartog, Hicham Zilaout, Wouter Goutier, Herman H van Stuivenberg, Bernard J van Vliet.   

Abstract

The synthesis and structure-activity relationship studies of imidazoles are described. The target compounds 6-20 represent a novel chemotype of potent and CB(2)/CB(1) selective cannabinoid CB(2) receptor antagonists/inverse agonists with very high binding efficiencies in combination with favourable logP and calculated polar surface area values. Compound 12 exhibited the highest CB(2) receptor affinity (K(i)=1.03 nM) in this series, as well as the highest CB(2)/CB(1) subtype selectivity (>9708-fold). Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20031412     DOI: 10.1016/j.bmcl.2009.12.032

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

Review 1.  Latest advances in novel cannabinoid CB(2) ligands for drug abuse and their therapeutic potential.

Authors:  Peng Yang; Lirong Wang; Xiang-Qun Xie
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

2.  Development of Highly Affine and Selective Fluorinated Cannabinoid Type 2 Receptor Ligands.

Authors:  Rareş-Petru Moldovan; Kristin Hausmann; Winnie Deuther-Conrad; Peter Brust
Journal:  ACS Med Chem Lett       Date:  2017-04-28       Impact factor: 4.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.